logo

Biotechnology News

Share
BELLUS Health Inc. (BLU), a clinical-stage biopharmaceutical company, announced Monday that its Phase 2 RELIEF trial of BLU-5937 in patients with refractory chronic cough failed to achieve statistical significance for the primary endpoint. In pre-market activity on Nasdaq, BELLUS shares were trading...
Read More
Mylan N.V. (MYL) announced Monday that the Drug Controller General of India or DCGI has approved its remdesivir 100 mg/vial for restricted emergency use in COVID-19 patients in India. The drug is approved for the treatment of suspected or laboratory confirmed incidences of COVID-19 in adults and children...
Golden Biotechnology Corp., a Taiwanese biopharmaceutical company, said the FDA approved its investigational new drug application for a Phase II clinical trial of Antroquinonol (Hocena) on COVID-19 patients in USA. The phase II trial will be a randomized, double-blinded, placebo-controlled study of Antroquinonol...
EMD Serono, the biopharmaceutical business of Merck KGaA (MKGAY.PK), and Pfizer Inc. (PFE) announced the US FDA has approved the supplemental Biologics License Application for BAVENCIO (avelumab) for the maintenance treatment of patients with locally advanced or metastatic urothelial carcinoma that has...
Read More
stockmarkets dec26 06jul20 What's moving these stocks in the pre-market today?
pharma 032317 03jul20 Today's Daily Dose brings you news about BioLife Solutions' preliminary second-quarter revenue estimate; Immunomedics' immediate catalyst; Interpace Biosciences' stock price spike; MEI Pharma discontinuing Pracinostat trial in AML patients due to lack of efficacy and disappointing outcome from Regeneron/Sanofi's study evaluating Kevzara in COVID-19 patients.
stockmarkets jan22 02jul20 What's moving these stocks in the pre-market today?
Read More

listeriaconcerns july01

Garland Ventures Ltd is recalling Five Cheese Stuffed Shells citing possible presence of Listeria monocytogenes, the U.S. Food and Drug Administration said in a statement. The recall involves 1095 cases of Five Cheese Stuffed Shells trays that was distributed across the nation in limited number of retail stores.

norpac july01

Norpac Fisheries Export is recalling shrimp poke citing potential to be contaminated with Listeria monocytogenes, the U.S. Food and Drug Administration said in a statement.The recall involves all fresh shrimp poke distributed between May 11 and June 25 in the Hawaiian Island. The product was supplied on The Big Island, Maui, Oahu, and Kauai through its retail customers, specifically Safeway Stores

saniderm june30

UVT, Inc. recalled 38,830 liters of Saniderm Advanced Hand Sanitizer following a warning by the U.S. Food and Drug Administration about the potential presence of undeclared Methanol, a toxic chemical. The FDA last week urged consumers not to use any hand sanitizer products made by Mexico-based Eskbiochem SA de CV.

ttdeye june25

Chengdu Ai Qin E-commerce Co., Ltd has recalled 1362 pairs of TTDeye Brand colored contact lenses, which were found to be distributed without FDA clearance and may pose a threat to health, the U.S. Food and Drug Administration said in a statement.

Read More
Date Company Name Ticker Drug Event Outcome Details
12/30/2020 Athenex, Inc. ATNX Tirbanibulin Ointment (NDA) FDA decision on Tirbanibulin Ointment for the treatment of actinic keratosis
12/27/2020 Mylan N.V. MYL MYL-1402O (BLA) FDA decision on MYL-1402O, a proposed biosimilar to Avastin
12/26/2020 Urovant Sciences Ltd. UROV Vibegron (NDA) FDA decision on Vibegron for the treatment of overactive bladder
12/20/2020 AstraZeneca PLC AZN.L, AZN Roxadustat (NDA) FDA decision on Roxadustat for the treatment of anemia of chronic kidney disease (CKD), in both non-dialysis-dependent and dialysis-dependent patients
12/20/2020 Myovant Sciences Ltd MYOV Relugolix (NDA) FDA decision on once-daily, oral Relugolix for the treatment of men with advanced prostate cancer
12/20/2020 FibroGen Inc. FGEN Roxadustat (NDA) FDA decision on Roxadustat for the treatment of anemia of chronic kidney disease (CKD), in both non-dialysis-dependent and dialysis-dependent patients
12/19/2020 Amgen Inc. AMGN ABP 798 (BLA) FDA decision on ABP 798 (biosimilar rituximab) for Non-Hodgkin's lymphoma and Rheumatoid arthritis
12/18/2020 MacroGenics Inc. MGNX Margetuximab (BLA) FDA decision on Margetuximab for the treatment of patients with metastatic HER2-positive breast cancer in combination with chemotherapy
Read More
Results Date Company Name Ticker Event Indication Outcome
Q4 2020 SOLIGENIX, INC. SNGX Final results from phase III study of SGX942 (dusquetide) Oral mucositis in patients with head and neck cancer
Q4 2020 Catabasis Pharmaceuticals, Inc. CATB Top-line results from phase III trial of Edasalonexent (POLARIS DMD) Duchenne muscular dystrophy
Oct 2020 Tracon Pharmaceuticals, Inc. TCON Completion of Phase 1/2A Study Metastatic castrate resistant prostate cancer
Q4 2020 RHYTHM PHARMACEUTICALS, INC. RYTM Topline data from phase III trial of Setmelanotide BBS and Alström syndrome
Q4 2020 PhaseBio Pharmaceuticals Inc PHAS Results from Phase 2b clinical trial of PB1046 Pulmonary Arterial Hypertension
Read More
Seattle, Washington-based Accolade Inc. is scheduled to list its IPO on the Nasdaq Global Select Market under the symbol "ACCD" on July 2, 2020. The initial public offering price is expected to be between $19.00 and $21.00 per share.
Shares of Vaxart Inc. (VXRT) closed at a two-year high of $6.26 on Thursday, thanks to the Company's pipeline progress, especially the COVID-19 vaccine program.
Read More
Sunday, the lowest daily COVID-19 death toll in 103 days was reported in the United States. With 212 new deaths reporting in the last 24 hours, the total number of people who died due to the disease in the U.S. increased to 129,947, as per Johns Hopkins University's latest update on Monday. The last time a figure lower than this was recorded on March 24.This is less than 10 percent of daily de
Organigram Holdings Inc., the parent company of Canada-based cannabis producer Organigram Inc., said it will reduce its workforce by about 25 percent in order to "better align its production capacity to prevailing market conditions." According to Organigram, the decision to cut jobs will impact its...
Read More
The first half of 2020 looks set to end on an encouraging note for new drug approvals despite the ongoing coronavirus pandemic. Let's take a look at the biotech stocks facing FDA decision in July.
When will a safe and effective vaccine for COVID-19 be ready? Vaccine makers are racing against time to develop a vaccine to fight the novel coronavirus. There are more than 130 candidate vaccines in development against SARS-COV-2, the pathogen that causes COVID-19, of which 10 have moved into clinical trials.
Read More
Shares of Adaptive Biotechnologies Corp. (ADPT) have gained over 200 percent from their 52-week low of $15.19, recorded in March of this year, and trade around $46.
Shares of Personalis Inc. (PSNL) are down 61 percent from their 52-week high of $31.88, recorded last June, and trade around $12.
Read More